Trade Summary

6 days ago, Pelish Henry E., serving as Chief Scientific Officer at Nuvalent, Inc. (NUVL), sold 35,104 shares at $98.08 per share, for a total transaction value of $3,442,856.00. Following this transaction, Pelish Henry E. now holds 65,604 shares of NUVL.

This sale represents a 35.00% decrease in Pelish Henry E.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, March 12, 2026 and publicly disclosed via SEC Form 4 filing on Monday, March 16, 2026, 4 days after the trade was made.

Nuvalent, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.